Format

Send to

Choose Destination
Nat Rev Drug Discov. 2018 Sep;17(9):607-608. doi: 10.1038/nrd.2018.28. Epub 2018 Mar 23.

Accelerating the development of therapeutic strategies for drug-resistant tuberculosis.

Author information

1
Veterans Affairs Medical Center, Washington, DC, USA.
2
Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK.
3
Division of Infection and Immunity, University College London, London, UK.
4
NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK.

Abstract

Recent progress in the discovery, development and evaluation of new drugs and combination regimens for drug-resistant tuberculosis through greater collaboration between industry, donors and academia provides renewed hope for overcoming the challenges in tuberculosis treatment.

PMID:
29567994
DOI:
10.1038/nrd.2018.28

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center